Kelly Deck - 01 Apr 2025 Form 4 Insider Report for Inhibrx Biosciences, Inc. (INBX)

Role
Chief Financial Officer
Signature
/s/ Kelly Deck
Issuer symbol
INBX
Transactions as of
01 Apr 2025
Transactions value $
$0
Form type
4
Filing time
02 Apr 2025, 16:39:28 UTC
Previous filing
30 May 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INBX Stock Option (right to buy) Award $0 +15,000 $0 15,000 01 Apr 2025 Common Stock 15,000 $14.05 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Twenty-five percent (25%) of the total shares subject to this stock option will become exercisable on April 1, 2026, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date.